| Dr Robert Outenreath, PHD, MD | |
|
281 Sawyer Dr Ste 100, Durango, CO 81303-3409 | |
| (970) 259-2162 | |
| (970) 247-5255 |
| Full Name | Dr Robert Outenreath |
|---|---|
| Gender | Male |
| Speciality | Psychiatry & Neurology - Psychiatry |
| Location | 281 Sawyer Dr Ste 100, Durango, Colorado |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1598865610 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2084P0800X | Psychiatry & Neurology - Psychiatry | C41844 (California) | Secondary |
| 2084P0800X | Psychiatry & Neurology - Psychiatry | 0056827 (Colorado) | Primary |
| Entity Name | Santa Barbara County County Auditor |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1487857405 PECOS PAC ID: 9335052083 Enrollment ID: O20081226000157 |
News Archive
ISPOR the professional society for health economics and outcomes research, examined the issue of patient access and biosimilars this afternoon at its ISPOR 2019 annual conference with the session, "Improving Patient Access to Life Saving Therapies: What Needs to Be Done to Fulfill the Promise of Biosimilars?"
In a first for both institutions, Jupiter Medical Center, the area's Number One Preferred Hospital, and The Scripps Research Institute, one of the world's largest private, non-profit biomedical research organizations, are teaming up to conduct research on human cancer tissue.
Jamba, Inc. announced today the launch of its newest retail offering, the EZ-2 MAKE! Jamba Juice(TM) Smoothie and Ice Pop Maker, a Jamba Juice-branded toy blender designed to bring the smoothie-making experience to children nationwide. Created together with Think Wow Toys, the EZ-2 MAKE! Jamba Juice Smoothie and Ice Pop Maker will be available at a leading toy retailer, starting mid-November. The toy blender will be available to additional U.S. retailers beginning January 2010.
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues finds that, following its launch and uptake, GlaxoSmithKline's angiogenesis inhibitor Votrient (formerly Armala) will garner sales of $640 million by 2018 and will take significant market share away from Pfizer's Sutent. In 2008, Sutent had accounted for 61 percent of sales in the angiogenesis inhibitor drug class.
The 12 Million Euro 'GEN2PHEN' project, funded by the European Commission, aims to harness the web to capture and unify genetic information that fundamentally impacts on a person's health and disease processes.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Robert Outenreath, PHD, MD 250 Bon Air Rd, Greenbrae, CA 94904-1702 Ph: (415) 473-6769 | Dr Robert Outenreath, PHD, MD 281 Sawyer Dr Ste 100, Durango, CO 81303-3409 Ph: (970) 259-2162 |
News Archive
ISPOR the professional society for health economics and outcomes research, examined the issue of patient access and biosimilars this afternoon at its ISPOR 2019 annual conference with the session, "Improving Patient Access to Life Saving Therapies: What Needs to Be Done to Fulfill the Promise of Biosimilars?"
In a first for both institutions, Jupiter Medical Center, the area's Number One Preferred Hospital, and The Scripps Research Institute, one of the world's largest private, non-profit biomedical research organizations, are teaming up to conduct research on human cancer tissue.
Jamba, Inc. announced today the launch of its newest retail offering, the EZ-2 MAKE! Jamba Juice(TM) Smoothie and Ice Pop Maker, a Jamba Juice-branded toy blender designed to bring the smoothie-making experience to children nationwide. Created together with Think Wow Toys, the EZ-2 MAKE! Jamba Juice Smoothie and Ice Pop Maker will be available at a leading toy retailer, starting mid-November. The toy blender will be available to additional U.S. retailers beginning January 2010.
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues finds that, following its launch and uptake, GlaxoSmithKline's angiogenesis inhibitor Votrient (formerly Armala) will garner sales of $640 million by 2018 and will take significant market share away from Pfizer's Sutent. In 2008, Sutent had accounted for 61 percent of sales in the angiogenesis inhibitor drug class.
The 12 Million Euro 'GEN2PHEN' project, funded by the European Commission, aims to harness the web to capture and unify genetic information that fundamentally impacts on a person's health and disease processes.
› Verified 2 days ago
Dr. Susan Grayson, M.D. Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 303 Blue Spruce Trl, Durango, CO 81301 Phone: 970-259-0321 | |
Paula M Trautner, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 150 Rock Point Dr Ste B, Durango, CO 81301 Phone: 970-249-6116 Fax: 970-249-6116 | |
Patti Lynn Snodgrass, MD Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 281 Sawyer Dr, Suite 100, Durango, CO 81303 Phone: 970-259-2162 Fax: 970-247-5255 | |
Dr. Mark A Braunstein, DO Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 2855 Main Ave Suite A105, Four Courners Mental Health, Llc, Durango, CO 81301 Phone: 970-382-6690 Fax: 970-382-0207 | |
Mark David Fallon-cyr, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 281 Sawyer Dr, Suite 100, Durango, CO 81303 Phone: 970-259-2162 Fax: 970-247-0455 | |
Steve Kitson, MD Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 281 Sawyer Dr, Durango, CO 81303 Phone: 970-259-2162 | |
David Rushworth, M.D., PH.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 555 Rivergate Ln Ste B1-102, Durango, CO 81301 Phone: 970-844-2865 Fax: 970-837-3111 |